Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
Podcast
Exploring the Psych Effects of COVID and Emergence of PTSD in Comp
Workers' Comp
White Paper
Proven track records create a winning formula for injured workers’ recoveries
The coronavirus pandemic has taught us much about disparities in health care.
Disability
News Release
Genex Services Becomes Ticket to Work Provider
Social Security Initiative supports and protects people with disabilities who want to reenter workforce
Mitchell
News Release
New York State Workers' Compensation Board Announces Implementation Delay
The New York State Workers' Compensation Board announced on Monday, May 24, 2021, a delay in the implementation of the drug formulary for refills a
Workers' Comp
CE Webinar
Knee Injuries: Trends and Advances [Recording]
On-Demand
Knee injuries make up a large percentage of medical insurance and health care claims in the orthopedic field.
Workers' Comp
Podcast
The Truth About Mental Health and Claim Costs
Traditionally, the term mental health has been treated as a claims pariah in workers’ comp, as it’s been associated with delaying recovery and send